Stockscreener 앱 받기
10.03
0.10%
0.010
시간 외 거래:
10.04
0.010
+0.10%
New America Acquisition I Corp 주식(NWAX)의 최신 뉴스
A&O Shearman guides underwriter on TRG Latin America Acquisitions Corp.’s SPAC IPO - A&O Shearman
Drugs Made In America Acquisition Corp. issues $100,000 convertible note as part of $500,000 financing - Investing.com Australia
TRG Latin America's IPO grows to $206.3M after underwriter buys more units - Stock Titan
Complete List of Financial ServicesDiversified Financial ServicesShell Companies Stocks - GuruFocus
14,375,000 Ordinary Shares of Drugs Made In America Acquisition II Corp. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
Stefan Passantino Net Worth (2026) - GuruFocus
Drugs Made In America II (NASDAQ: DMII) plans $1.4M convertible note funding - Stock Titan
Dominari Holdings addresses congressional inquiry on Chinese IPOs - Investing.com
Dominari says IPOs are under 10% of revenue as House panel asks on China - Stock Titan
Boothbay Fund Management LLC Sells 70,000 Shares of Drugs Made In America Acquisition Corp. $DMAA - Defense World
Nscale Acquires American Intelligence & Power Corporation, Creating a Full Stack AI Hyperscaler, Integrated from Energy to Compute - Nscale
Donald Trump Jr. and Eric Trump back drone company Powerus - qz.com
Clear Street Group Inc. Acquires New Holdings in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Trump’s sons back new military drone venture tied to Pentagon work - Moneycontrol.com
Trump sons back launch of new military drone company - Financial Times
$50M KCGI bet, Trump investors behind new U.S. drone merger plan - Stock Titan
Drugs Made In America Acquisition II Corp. confirms trust account balance after review - Investing.com South Africa
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event | DMII SEC FilingForm 8-K - Stock Titan
Drugs Made In America Acquisition Corp. appoints new CEO after board changes - Investing.com Australia
Drugs Made In America Acquisition II Corp. appoints new CEO after sponsor repayment issue - Investing.com
CEO exits Drugs Made In America (NASDAQ: DMAA) after affiliate fund withdrawals - Stock Titan
Sponsor overpayment leads to CEO change at Drugs Made In America II (DMII) - Stock Titan
Drugs Made In America Acquisition II Corp. Announces CEO Changes, Effective February 28, 2026 - marketscreener.com
Context Capital Management LLC Buys Shares of 250,000 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Short Interest Down 21.7% in February - MarketBeat
TRG Latin America Acquisitions Corp. Completes $200 Million Initial Public Offering - The Manila Times
New $200M Nasdaq listing bundles TRG Latin America shares with rights - Stock Titan
TRG Latin America Acquisitions Corp. Announces Pricing of $200 Million Initial Public Offering - The Manila Times
Lake Superior Acquisition Corp.: Dividend historical data and projections - marketscreener.com
New America Acquisition I Corp. Class A Common Stock (NY: NWAX - The Chronicle-Journal
DermTech Stock (DMTK)Quote OTC Markets - marketscreener.com
New America Acquisition I Revamps Board, Appoints New Chair - TipRanks
Drugs Made In America Acquisition (NASDAQ:DMAA) Stock Price Up 0.1% – Here’s Why - Defense World
New America Acquisition I Corp appoints Kyle Wool as board chairman - Investing.com Nigeria
New America Acquisition I Corp. Appoints Kyle Wool as Chairman and Adds Stefan Passantino as Independent Director - The Globe and Mail
New America Acquisition I Corp appoints Kyle Wool as board chairman By Investing.com - Investing.com South Africa
New America Acquisition I Corp. Announces the Separate Trading of Its Shares of Class A Common Stock and Warrants, Commencing on January 26, 2026 - The Globe and Mail
New America Acquisition I announces separate trading of stock, warrants - TipRanks
SPAC New America lets investors trade its stock and warrants separately - stocktitan.net
5.77%
0.74%
자본화:
|
볼륨(24시간):